Results of a study investigating brentuximab vedotin combined with nivolumab for treatment of relapsed Hodgkin lymphoma. (Abstract only)
Home / Resource Library / Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3 year study results